High Tower Advisors, LLC Atai Life Sciences N.V. Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, High Tower Advisors, LLC holds 43,052 shares of ATAI stock, worth $55,967. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,052
Previous 44,189
2.57%
Holding current value
$55,967
Previous $87,000
34.48%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ATAI
# of Institutions
99Shares Held
12.7MCall Options Held
9.2KPut Options Held
118K-
Walleye Capital LLC Plymouth, MN2.76MShares$3.59 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.72MShares$3.53 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.7 Million0.0% of portfolio
-
Brown University719KShares$934,0500.39% of portfolio
-
Two Sigma Investments, LP New York, NY717KShares$932,2700.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $216M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...